Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study

H Hanai, F Watanabe, K Takeuchi, T Iida… - Clinical …, 2003 - Elsevier
Background & Aims: Active ulcerative colitis (UC) is characterized by infiltration of activated
granulocytes and monocytes/macrophages (GM) within the large bowel mucosa. GM are …
被引用次数：223 相关文章

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study

H Hanai, F Watanabe, K Takeuchi… - … : the official clinical …, 2003 - pubmed.ncbi.nlm.nih.gov
Background and aims Active ulcerative colitis (UC) is characterized by infiltration of activated
granulocytes and monocytes/macrophages (GM) within the large bowel mucosa. GM are …

[引用][C] Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study

H HANAI - Clin Gastroenterol Hepatol, 2003 - cir.nii.ac.jp
Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis : a prospective,
uncontrolled, pilot study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: A prospective, uncontrolled, pilot study

H Hanai, F Watanabe, K Takeuchi, T Iida… - Clinical …, 2003 - cghjournal.org
Abstract Background & Aims: Active ulcerative colitis (UC) is characterized by infiltration of
activated granulocytes and monocytes/macrophages (GM) within the large bowel mucosa …

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: A prospective, uncontrolled, pilot study

H Hanai, F Watanabe, K Takeuchi, T Iida… - Clinical …, 2003 - infona.pl
Background & Aims: Active ulcerative colitis (UC) is characterized by infiltration of activated
granulocytes and monocytes/macrophages (GM) within the large bowel mucosa. GM are …

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study.

H Hanai, F Watanabe, K Takeuchi, T Iida… - … and Hepatology: the …, 2003 - europepmc.org
Methods Thirty-one patients with active corticosteroid refractory (refractory) UC, mean age of
42 years, duration of UC 6 years, clinical activity index (CAI) of 15, disease activity index …

[引用][C] Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: A prospective, uncontrolled, pilot study

H Hanai, F Watanabe, K Takeuchi, T Iida… - Clinical …, 2003 - cir.nii.ac.jp
Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: A prospective,
uncontrolled, pilot study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …